HomeCompareNVRO vs PM

NVRO vs PM: Dividend Comparison 2026

NVRO yields 34.25% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVRO wins by $119.0K in total portfolio value
10 years
NVRO
NVRO
● Live price
34.25%
Share price
$5.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$168.6K
Annual income
$25,000.88
Full NVRO calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — NVRO vs PM

📍 NVRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVROPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVRO + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVRO pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVRO
Annual income on $10K today (after 15% tax)
$2,910.96/yr
After 10yr DRIP, annual income (after tax)
$21,250.75/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, NVRO beats the other by $19,132.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVRO + PM for your $10,000?

NVRO: 50%PM: 50%
100% PM50/50100% NVRO
Portfolio after 10yr
$109.1K
Annual income
$13,746.45/yr
Blended yield
12.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

NVRO
Analyst Ratings
9
Buy
19
Hold
4
Sell
Consensus: Hold
Price Target
$30.32
+419.2% upside vs current
Range: $4.00 — $125.00
Altman Z
-0.6
Piotroski
2/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVRO buys
0
PM buys
0
No recent congressional trades found for NVRO or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVROPM
Forward yield34.25%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$168.6K$49.6K
Annual income after 10y$25,000.88$2,492.02
Total dividends collected$120.7K$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy
Analyst price target$30.32$194.30

Year-by-year: NVRO vs PM ($10,000, DRIP)

YearNVRO PortfolioNVRO Income/yrPM PortfolioPM Income/yrGap
1← crossover$14,125$3,424.66$11,648$408.29+$2.5KNVRO
2$19,634$4,520.76$13,589$495.90+$6.0KNVRO
3$26,882$5,873.02$15,877$603.21+$11.0KNVRO
4$36,278$7,514.85$18,580$734.88+$17.7KNVRO
5$48,296$9,478.22$21,781$896.75+$26.5KNVRO
6$63,469$11,792.55$25,578$1,096.12+$37.9KNVRO
7$82,395$14,483.60$30,092$1,342.17+$52.3KNVRO
8$105,736$17,572.52$35,470$1,646.46+$70.3KNVRO
9$134,212$21,075.04$41,892$2,023.58+$92.3KNVRO
10$168,608$25,000.88$49,578$2,492.02+$119.0KNVRO

NVRO vs PM: Complete Analysis 2026

NVROStock

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Full NVRO Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this NVRO vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVRO vs SCHDNVRO vs JEPINVRO vs ONVRO vs KONVRO vs MAINNVRO vs MONVRO vs BTINVRO vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.